Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy.
Eur J Radiol
; 170: 111198, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-37992608
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Limits:
Humans
Language:
En
Journal:
Eur J Radiol
Year:
2024
Document type:
Article